PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported February 28, 2024

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Recall #
Z-1174-2024
Affected scope
3,080,000 syringes
Initiated
December 28, 2023
Compiled from official public sources by the editorial team.
Verify with FDA Devices →
View my saved recalls

Mrp, LLC dba Aquabiliti recalled AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805;… - a moderate-severity action.

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805;… was recalled by Mrp, LLC dba Aquabiliti in February 28, 2024. Reason: The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.. Check the official notice for the remedy. Verify recall #Z-1174-2024 with the FDA Devices before acting.

The recall

Mrp, LLC dba Aquabiliti issued this moderate-severity FDA Devices recall — The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months..

Moderate
severity level
Class II
classification
February 28, 2024
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1174-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-1174-2024) was formally reported on February 28, 2024, with the manufacturer initiating the action on December 28, 2023. It is classified under Moderate severity (Class II), with a current status of Ongoing. Mrp, LLC dba Aquabiliti is listed as the recalling firm, operating out of Nashville, TN. Federal records list the affected scope as 3,080,000 syringes.

The documented reason for this recall is: The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months. Distribution data in the federal record shows the product reached: US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category — 40,409 medical devices recalls on record

-1,00001,0002,0003,0004,0005,000 20052008201120142017202020232026 1,243

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

3,080,000 syringes

Related Recalls

6

6 from same agency

Product description

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

Reason for recall

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-1174-2024
Date reported February 28, 2024
Date initiated December 28, 2023
Recalling firm Mrp, LLC dba Aquabiliti
Firm location Nashville, TN
Affected scope 3,080,000 syringes
Distribution US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1174-2024) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting — recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.. Recalled by Mrp, LLC dba Aquabiliti. Units affected: 3,080,000 syringes.
Why was this product recalled?
The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 28, 2024. Severity: Moderate. Recall number: Z-1174-2024.
Where was the recalled product distributed?
Distribution: US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-1174-2024) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with GE HealthCare TRADE IN CARESCAPE TELEMETRY SERVER ARK-2250L… →

Browse all Medical Devices recalls →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Devices, reported February 28, 2024.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.